Skip to main content
Medtronic8-K: Material contract

Medtronic to take a $157M charge in Q4 FY26 related to its MiniMed Flex™ R&D funding agreement with Blackstone.

What happened

A one-time charge of $157 million will be recognized in Q4 FY26 to cover future royalty and milestone payments to Blackstone for the MiniMed Flex development. This significant, immediate financial impact will likely trigger reviews of project ROI, financial planning, and accounting systems.

Source

SEC EDGARMar 24, 2026

Current report (Form 8-K)

Medtronic 8-K

Filing excerpt

Under the research and development agreement between MiniMed and Blackstone, in exchange for funding the development of the MiniMed Flex, during the first two years following regulatory approval in the U.S. and commercial launch of the MiniMed Flex, Blackstone will earn the greater of: (i) mid-to-high single digit royalty percentage of applicable net sales, and (ii) specified minimum payments.

sec.gov/Archives/edgar/data/1613103/000161310326000005/mdt-20260324.htmRead the full source

Other signals in this filing (5)

Extracted by Autobound

From the Signal API record
Signal
8-K: Material contract

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
03/24
Filed
Mar 24, 2026

The full record

From the Signal API record

Numbers

Dollar figure
$157M (One-time charge in Q4 FY26 related to future payments due to Blackstone for MiniMed Flex development.)

Details

CIK
1613103
Accession number
0001613103-26-000005
Timeframe
Current quarter
Filing year
2026
Why it matters
Vendor relationship signal
Signal category
Strategic

Topics and mentions

Vendors

  • Blackstone Life Sciences Advisors L.L.C.

Extraction

Confidence
High
Relevance
90%
Sentiment
Negative
Detected
Mar 31, 2026
signal_type
sec-8k
signal_subtype
materialContract

Use this data

Get every 8-K signal for Medtronic and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medtronic this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/f4aee36f-0106-4380-9acb-68159428c06f returns this record as JSON. POST /v1/companies/enrich returns every signal for medtronic.com.

{
  "signal_id": "f4aee36f-0106-4380-9acb-68159428c06f",
  "signal_type": "sec-8k",
  "signal_subtype": "materialContract",
  "detected_at": "2026-03-31T08:16:22.923+00:00",
  "company": {
    "name": "Medtronic",
    "domain": "medtronic.com"
  },
  "data": {
    "detail": "A one-time charge of $157 million will be recognized in Q4 FY26 to cover future royalty and milestone payments to Blackstone for the MiniMed Flex development. This significant, immediate financial impact will likely trigger reviews of project ROI, financial planning, and accounting systems.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "One-time charge in Q4 FY26 related to future payments due to Blackstone for MiniMed Flex development.",
      "dollar_millions": 157
    },
    "summary": "Medtronic to take a $157M charge in Q4 FY26 related to its MiniMed Flex™ R&D funding agreement with Blackstone.",
    "excerpts": "Under the research and development agreement between MiniMed and Blackstone, in exchange for funding the development of the MiniMed Flex, during the first two years following regulatory approval in the U.S. and commercial launch of the MiniMed Flex, Blackstone will earn the greater of: (i) mid-to-high single digit royalty percentage of applicable net sales, and (ii) specified minimum payments.",
    "relevance": 0.9,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1613103/000161310326000005/mdt-20260324.htm",
    "filing_date": "2026-03-24",
    "filing_year": 2026,
    "fiscal_year_end": "03/24",
    "sales_relevance": "Vendor relationship signal",
    "signal_category": "strategic",
    "vendors_mentioned": [
      "Blackstone Life Sciences Advisors L.L.C."
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.